Last reviewed · How we verify
NCT05706220
Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
trial testing Eye tracking in Multiple Sclerosis in 120 participants. Enrolling by invitation.
31 December 2025
Quick facts
| Lead sponsor | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 13 June 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Eye tracking
- Microperimetry
- Optical coherence tomography (OCT)
- Visual processing speed test
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Clinically Isolated Syndrome — all drugs for Clinically Isolated Syndrome →
- Relapsing Remitting Multiple Sclerosis — all drugs for Relapsing Remitting Multiple Sclerosis →
- Progressive Multiple Sclerosis — all drugs for Progressive Multiple Sclerosis →
Sponsor
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Who can join
Adults 18 to 80, any sex, with Multiple Sclerosis or Clinically Isolated Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Correlations Between Disability Score, Optical Coherence Tomography and Microperimetry in Patients with Multiple Sclerosis.
Guantay CD, Mena-García L, Tola-Arribas MÁ, Garea García-Malvar MJ, et al · · 2024 · PMID 39553841 · DOI 10.2147/eb.s469182
Verify or expand the search:
- PubMed search for NCT05706220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Eye tracking
Trials testing the same drug.
- NCT06470269 — Examining Clinical Reasoning With Eye-tracking · completed
- NCT03829787 — Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder · recruiting
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA trials
Trials by the same sponsor.
- NCT05290727 — Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort · NA · completed
- NCT05187533 — Sphenopalatine Ganglion Stimulation for Ocular and Oral Dryness · NA · completed
- NCT04937725 — Reading Problems Associated With Central Nervous System (CNS) Pathologies. · completed
- NCT04972695 — Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images · completed
- NCT04492878 — Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05706220 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- Last refreshed: 16 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05706220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing